Anthracyclines in the Treatment of Early-Stage Breast Cancer: Ally or Adversary?

By Lyman Gary H.  

Cancer Investigation, Vol. 28, Iss. 3, 2010-03 ,pp. : 217-219

Informa Healthcare

Access to resources Recommend Favorite

Classification of ipsilateral breast tumor recurrence after breast-conserving therapy: New primary cancer allows a good prognosis

By Nishimura Seiichiro  

Breast Cancer, Vol. 12, Iss. 2, 2005-04 ,pp. : 112-117

Springer Publishing Company

Access to resources Recommend Favorite

A longitudinal study of factors associated with perceived risk of recurrence in women with ductal carcinoma in situ and early-stage invasive breast cancer

By Liu Ying  

Breast Cancer Research and Treatment, Vol. 124, Iss. 3, 2010-12 ,pp. : 835-844

Springer Publishing Company

Access to resources Recommend Favorite

Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation

By Woodward W.A.   Strom E.A.   Tucker S.L.   Katz A.   McNeese M.D.   Perkins G.H.   Buzdar A.U.   Hortobagyi G.N.   Hunt K.K.   Sahin A.   Meric F.   Sneige N.   Buchholz T.A.  

International Journal of Radiation Oncology*Biology*Physics, Vol. 57, Iss. 2, 2003-10 ,pp. : 336-344

Elsevier

Access to resources Recommend Favorite

Serum Lipids and Outcome of Early-stage Breast Cancer: Results of a Prospective Cohort Study

By Bahl Mala  

Breast Cancer Research and Treatment, Vol. 94, Iss. 2, 2005-11 ,pp. : 135-144

Springer Publishing Company

Access to resources Recommend Favorite